TACSTD2 and neoplasm: The trispecific Trop2/CD3/CDH-17 binding molecule effectively mediated the lysis of Trop2+ CDH-17+ cells in vitro and induced significant tumor regression in vivo in human xenograft mouse models (HPAF-II) reconstituted with human T cells.